HCM
HUTCHMED (China) (HCM) Investor Questions
Review HUTCHMED (China) (HCM) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- HUTCHMED (China)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Overall BTI score
- 42
- Annual revenue
- $549.96M
- Annual net income
- $458.12M
- Annual free cash flow
- $-88.81M
HUTCHMED (China) (HCM) Investor Questions research
HUTCHMED (China) trades under the ticker HCM. The company is classified in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry.
Investors commonly review HCM through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.